Four companies, from the United States, India and China, will offer rapid H.I.V. tests for 49 cents to 65 cents, which will reduce the typical cost of a test in poor countries by half, Mr. Clinton said in a written statement. Another four companies - three from India and one from South Africa - will make the antiretroviral drug efavirenz for as little as $240 per patient per year. One of the Indian companies, Cipla, will also make the antiretroviral abacavir for $447." (NYTimes)